ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 4 for:    theodore leng
Previous Study | Return to List | Next Study

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02422160
Recruitment Status : Recruiting
First Posted : April 21, 2015
Last Update Posted : August 21, 2018
Sponsor:
Information provided by (Responsible Party):
Theodore Leng, Stanford University

Brief Summary:
The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.

Condition or disease Intervention/treatment
Age-Related Macular Degeneration Other: No interventions are planned

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
Study Start Date : April 2015
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: No interventions are planned
    No interventions are planned


Primary Outcome Measures :
  1. Visual Acuity [ Time Frame: Two Years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with non-exudative age-related macular degneration
Criteria

Inclusion Criteria:

  • Non-exudative age-related macular degeneration

Exclusion Criteria:

  • Exudative age-related macular degeneration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02422160


Contacts
Contact: Theodore Leng, MD 650-723-6995

Locations
United States, California
Byers Eye Institute at Stanford Recruiting
Palo Alto, California, United States, 94303
Contact: Theodore Leng, MD    650-723-6995      
Principal Investigator: Theodore Leng, MD         
Sponsors and Collaborators
Stanford University

Responsible Party: Theodore Leng, Principle Investigator, Stanford University
ClinicalTrials.gov Identifier: NCT02422160     History of Changes
Other Study ID Numbers: 33624
First Posted: April 21, 2015    Key Record Dates
Last Update Posted: August 21, 2018
Last Verified: August 2018

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases